Replies to post #432100 on Elite Pharmaceuticals Inc (ELTP)

[IB_]

So far, that is the most truthful post of the YEAR !!!!!!!!!!!!!

He is a lawyer ... as long as it can be argued that "it" is legal, he has no problem doing it .................

I believe the only way to get him to change his self-serving behavior, is to do so with legal influence,

IB_🤴

[HGiLS]

In my opinion, Nasrat checks all the boxes.

If he had not bought half of the Adderall with Mikah, the company would not be functioning today, or we would have 2 plus billion shares.
-----------------------------------------

v A CEO's fiduciary duty is a legal obligation to act in the best interests of the company and its shareholders. This duty encompasses several key components: loyalty, care, and good faith. Essentially, a CEO must prioritize the company's well-being over their own and act with diligence, honesty, and transparency in all corporate matters.

Key aspects of a CEO's fiduciary duty:

Duty of Care:
.
v This requires the CEO to make informed decisions, acting with the same level of diligence and prudence that a reasonable person would in a similar situation. This includes being well-informed about the company's operations, considering all relevant information before making decisions, and avoiding negligence or recklessness.

Duty of Loyalty:

v This means the CEO must act in the best interests of the company and its shareholders, putting their needs above their own. This includes avoiding conflicts of interest, not using company resources for personal gain, and not taking advantage of corporate opportunities for personal benefit.

Duty of Good Faith:
.
v This duty requires the CEO to act honestly, fairly, and with integrity in all corporate dealings. It also includes a duty of obedience, requiring the CEO to act within the bounds of the law and the company's governing documents.

[kayak_wench]

Nope I'm bowing out this discussion.
I really don't care about people posting the Narsat Mikah crap anymore. I am just going to tell them to take it to court and let us know how it turns out.

I'll leave the part about the value of trimipramine to Elite. As it highlights how these people do not think about anything before they make their claims. Again, Nasrat just a few weeks ago highlighted trimipramine as one of the stand out legacy products that they want to quickly fold into their private marketing. Meaning not only was it not a bad deal, it continues to be a profitable product.

Its not hard to take a guess at how profitable. Manufacturing costs are low because there is nothing special about its API.

The estimated cost to manufacture trimipramine is $50–$150 per patient per year.
Lets call that $150 per year to worst case it.
Best price for patients right now is about 50cents a pill, but averages a dollar and its taken 1 to 3 times a day.
I wam going to assume a price of 75cents per day or about $300 a year.
So Elite can sell it for at least twice what it costs to manufacture.
The market is pretty much 100% generic at this point.
At the estimated sales from 8 years ago (before price increased by 2 to three times, so this is very much low balling it) that would be $1M in revenue of which $500k would be pure profit.
It is obvious at that profit rate trimipramine generated at least $2.5M in the past five years. More than making the purchase at a bit over $1M worth it. But again that is based on old sales numbers. The cost has increased a good bit as the drug has become less used.